Lung Cancer ECOG 1505

March 13, 2013

Location: The Hospital of Central Connecticut

A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (>/=4cm) – IIIA NSCLC.